As-Needed Albuterol–Budesonide in Mild Asthma

As-needed use of albuterol-budesonide resulted in a lower risk of a severe asthma exacerbation than as-needed use of albuterol alone among participants with disease that was uncontrolled despite treatment for mild asthma. (Funded by Bond Avillion 2 Development and AstraZeneca; BATURA ClinicalTrials.gov number, NCT05505734.)See also in <i>NEJM</i> Evidence: Participants as Partners in Decentralized Clinical Trials.